InvestSMART

4DMedical Limited (ASX: 4DX) - Announcements

Current share price for 4DX : $4.270 0.04 (0.93%)+

ASX company news and announcements for 4DMedical Limited (4DX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All 4DMedical Limited (4DX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than 4DMedical Limited (4DX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for 4DMedical Limited (4DX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$2,629 4DMedical to present at NWR Virtual Healthcare Day 24 Nov 2021 9:22AM $1.385 $4.370 risen by 215.52%
$2,629 First commercial scans with I-MED to commence in December 23 Nov 2021 8:27AM $1.200 $4.370 risen by 264.17%
$2,629 4DMedical presents at BP Healthcare Conference 9 Nov 2021 2:23PM $1.365 $4.370 risen by 220.15%
$2,629 Notification of cessation of securities - 4DX 3 Nov 2021 2:46PM $1.425 $4.370 risen by 206.67%
$2,629 Notification regarding unquoted securities - 4DX 3 Nov 2021 2:41PM $1.425 $4.370 risen by 206.67%
$2,629 Appendix 3Z - LG 28 Oct 2021 4:39PM $1.340 $4.370 risen by 226.12%
$2,629 Appendix 3Z - HL 28 Oct 2021 4:39PM $1.340 $4.370 risen by 226.12%
$2,629 Results of Meeting 28 Oct 2021 4:34PM $1.340 $4.370 risen by 226.12%
$2,629 2021 Annual General Meeting presentation 28 Oct 2021 1:32PM $1.315 $4.370 risen by 232.32%
$2,629 Chairman's Address to Shareholders 28 Oct 2021 1:30PM $1.315 $4.370 risen by 232.32%
$2,629 Quarterly Activity Report and Appendix 4C for Q1 FY2022 25 Oct 2021 9:25AM $1.360 $4.370 risen by 221.32%
$2,629 2021 Notice of Annual General Meeting 28 Sep 2021 10:43AM $1.460 $4.370 risen by 199.32%
$2,629 Appendix 4G and Corporate Governance Statement 23 Sep 2021 8:44AM $1.440 $4.370 risen by 203.47%
$2,629 2021 Annual Report 23 Sep 2021 8:44AM $1.440 $4.370 risen by 203.47%
$2,629 4DMedical advances Australian clinical pilot with I-MED 1 Sep 2021 8:32AM $1.595 $4.370 risen by 173.98%
$2,629 2021 Annual General Meeting 31 Aug 2021 10:54AM $1.545 $4.370 risen by 182.85%
$2,629 FY21 Full Year Results 24 Aug 2021 9:03AM $1.420 $4.370 risen by 207.75%
$2,629 Appendix 4E - Preliminary Final Report 24 Aug 2021 8:58AM $1.420 $4.370 risen by 207.75%
$2,629 Change in substantial holding 23 Aug 2021 3:44PM $1.415 $4.370 risen by 208.83%
$2,629 Change of interests of substantial holder - Velocimetry & HF 10 Aug 2021 12:49PM $1.595 $4.370 risen by 173.98%
$2,629 Change of interests of substantial holder - 4DMedical 10 Aug 2021 12:45PM $1.595 $4.370 risen by 173.98%
$2,629 4DMedical secures contract with pharmaceutical company 9 Aug 2021 9:20AM $1.490 $4.370 risen by 193.29%
$2,629 Application for quotation of securities - 4DX 30 Jul 2021 10:05AM $1.535 $4.370 risen by 184.69%
$2,629 Release of restricted securities from escrow 30 Jul 2021 9:55AM $1.490 $4.370 risen by 193.29%
$2,629 4DMedical to present at NWR virtual investor conference 28 Jul 2021 9:04AM $1.445 $4.370 risen by 202.42%

476 - 500 of 597 results

Page 20 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.